Literature DB >> 1005106

Preleukemic states. I. Definition and classification. II. Refractory anemia with an excess of myeloblasts in the bone marrow (smoldering acute leukemia).

B Dreyfus.   

Abstract

Approaches to the diagnosis and classification of preleukemic states involving chronic cytopenias are presented and discussed. Diagnosis of these states is facilitated by the identification of anomalies in all the myeloid cell lines (i.e., those derived from the bone marrow). These cellular anomalies may be morphologic, biochemical, or functional in nature or may affect the quantity of cell in each line in the bone marrow and the peripheral blood. Such anomalies may occur alone or may be associated. A tentative classifiction is proposed which is based on one or several of these anomalies. Among the quantitative criteria of classification is a moderate and static excess of myeloblasts and promyelocytes in the bone marrow. Refractory anemia with an excess of myeloblasts (RAEM) in the most frequent of these states. Its main clinical and hematologic features are described. The disease course is quite typical, the mean survival being 20 months; some patients survive for more than 30 months. Acute myeloid leukemia (AML) was the cause of death in less than 28% of cases. Infection in the absence of severe neutropenia was frequent. The relationship between RAEM and AML is disc,ssed, and the individual characteristics of RAEM are emphasized.

Entities:  

Mesh:

Year:  1976        PMID: 1005106

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol Blood Cells


  11 in total

1.  Does a diagnosis of myelogenous leukemia require 20% marrow myeloblasts, and does <5% marrow myeloblasts represent a remission? The history and ambiguity of arbitrary diagnostic boundaries in the understanding of myelodysplasia.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2013-08-27

2.  Ring sideroblasts and myelodysplastic syndromes.

Authors:  M Cazzola
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

3.  Impaired T-cell and NK-cell function in patients with preleukemia.

Authors:  F Porzsolt; H Heimpel
Journal:  Blut       Date:  1982-10

4.  Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases.

Authors:  S K Juneja; M Imbert; H Jouault; J Y Scoazec; F Sigaux; C Sultan
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

Review 5.  The preleukemic syndromes (hematopoietic dysplasia) in childhood.

Authors:  E Kleihauer
Journal:  Eur J Pediatr       Date:  1980       Impact factor: 3.183

6.  Dysmyelopoiesis in the cat: a hematological disorder resembling refractory anemia with excess blasts in man.

Authors:  R J Baker; V E Valli
Journal:  Can J Vet Res       Date:  1986-01       Impact factor: 1.310

7.  [A prospective study on course and prognostic criteria in "preleukemia" (author's transl)].

Authors:  H Heimpel; P Drings; P Mitrou; W Queisser
Journal:  Klin Wochenschr       Date:  1979-01-01

8.  Myeloid dysplasia (MD): a hematological disorder preceding acute and chronic myeloid leukemia. A morphological study on sequential core biopsies of the bone marrow in 27 patients.

Authors:  J Thiele; K F Vykoupil; A Georgii
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

9.  Partial myeloperoxidase deficiency in preleukemia.

Authors:  P Cech; M Markert; L H Perrin
Journal:  Blut       Date:  1983-07

10.  Natural history of smouldering leukaemia.

Authors:  A S Joseph; K I Cinkotai; L Hunt; C G Geary
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.